CD8A and Epstein-Barr virus infection: In the case of persistent EBV infection, the latent phase protein EBNA3 provokes the highest immunogenicity for CD8+ T cells, and other EBV proteins, like EBNA1, LMP1 and LMP2, have also been identified as its targets [81,82].